Triple-negative breast cancer (TNBC) is the deadliest form of breast cancer. Unlike other 15 types of breast cancer that can be effectively treated by targeted therapies, no such targeted 16 therapy exists for all TNBC patients. The ADAR1 enzyme carries out A-to-I editing of RNA to 17 prevent sensing of cellular double-stranded RNAs (dsRNA). ADAR1 is highly expressed in 18 breast cancer including TNBC. Here, we demonstrate that ADAR1 expression and editing 19 activity is required in TNBC cell lines but not in ER+ and/or Her2+ cells. In TNBC cells, 20 knockdown of ADAR1 attenuates proliferation and tumorigenesis. PKR expression is elevated in 21 TNBC and its activity is induced upon ADAR1-knockdown, which correlates with a decrease in 22 translation. ADAR1-dependent TNBC cell lines also exhibit elevated IFN stimulated gene 23 expression. IFNAR1 reduction significantly rescues the proliferative defects of ADAR1 loss.
Introduction 29
Generally defined by the lack of estrogen receptor (ER), progesterone receptor (PR) and 30 HER2 expression, triple-negative breast cancer (TNBC) accounts for 15 to 20 percent of all 7 proliferation in MDA-MB231 TNBC cells. Having established a rescue system for ADAR1 120 dependent proliferation, we next aimed to determine whether the editing activity of ADAR1-121 p150 was required for this rescue. An editing-defective mutant (E912A) of the p150 isoform was 122 incapable of rescuing the ADAR1 knockdown phenotype, indicating that the A-to-I editing 123 function of ADAR1 is absolutely required for cellular proliferation in TNBC cells ( Figure 1I-J) . 124 ADAR1 is required for TNBC transformation and tumorigenesis 125 To assess the functional relevance of our findings, we investigated the requirement of 126 ADAR1 for the transformation of breast cancer cell lines. We utilized anchorage independent 127 growth in soft agar as a measure of cellular transformation. Knockdown of ADAR1 dramatically 128 reduced soft agar colonies of MDA-MB231 and HCC1806 TNBC cells while not significantly 129 affecting the numbers of colonies formed by SKBR3 and T47D non-TNBC cells (Figure 2A-D) . 130 To extend these in vitro findings, we next determined whether ADAR1 was required for 131 TNBC cell lines to form tumors in vivo. We performed mammary gland orthotopic form tumors in transplanted mice. In contrast, ADAR1 knockdown in SKBR3 cells did not 138 significantly affect tumor formation in transplanted mammary glands. Collectively, these results 139 demonstrate that ADAR1 expression is required for in vitro transformation and in vivo tumor 140 formation of TNBC cells, but is completely dispensable for these properties in non-TNBC cells. Previous reports have shown that ADAR1 dependency in human cancer cells could be 143 mediated through several downstream pathways, including translational inhibition triggered by 144 activated PKR and ribonuclease L (RNASEL), as well as type-I IFN signaling (Li et al., 2017 , 145 Gannon et al., 2018 , Liu et al., 2019 . To investigate if these pathways contribute to the ADAR1 146 dependency observed in TNBC cells, we first analyzed the TCGA and CCLE datasets to 147 determine if these pathways are intrinsically elevated in TNBC. Across TCGA breast cancer 148 samples, RNA expression of PKR is significantly higher in TNBC samples compared to non-149 TNBC ( Figure 3A ). This is consistent with RNA-seq data for breast cancer cell lines within the 150 CCLE ( Figure 3B ). Moreover, elevated PKR expression positively correlates with the ADAR1 151 sensitivity scores, suggesting a strong relationship between PKR and TNBC-associated ADAR1 , 1983) . However, we did not observe rRNA degradation in ADAR1-175 dependent TNBC cells after ADAR1 knockdown (Supplemental Figure 3H) , further suggesting 176 that the RNASEL pathway does not significantly contribute to TNBC-associated ADAR1 177 dependency and the induction of OAS genes likely reflects the fact that OAS genes are also 178 known ISGs (see below).
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PKR is overexpressed in TNBC and activated upon ADAR loss
179
ADAR1-dependent TNBCs exhibit elevated ISG expression 180
Another factor contributing to ADAR1 dependency in cancer cell lines is the type-I IFN makes select cancer cell lines ADAR1-dependent, or conversely why others are refractory to 215 ADAR1-loss. It has been proposed that the higher ISG expression might potentiate these cells 216 towards ADAR1-dependency -loss of ADAR1 would further elevate ISG expression leading to 217 the growth inhibition phenotype (Liu et al., 2019 , Gannon et al., 2018 . However, we have 218 demonstrated that for cell lines refractory to ADAR1 loss, treatment with IFN-β did not render 219 them sensitive to ADAR1 knockdown. Furthermore, we observed no activation of PKR in the 220 ADAR1 refractory cell lines following ADAR1 loss. These findings suggest that the link 221 between ADAR1 loss and the IFN pathway or PKR activation in ADAR1-refractory cell lines is 222 missing. Loss of ADAR1 is thought to activate the IFN pathway and PKR by causing an increase 223 in dsRNA -stemming from a reduction in A-to-I editing (Mannion et al., 2014 , Liddicoat et al., 224 2015 . It is possible that ADAR1-refractory cell lines either do not accumulate dsRNA following 225 ADAR1 loss or there exists a system that prevents dsRNAs from activating the IFN pathway or 226 PKR. Understanding the molecular basis of this process would help to predict which cell lines -227 or more importantly which tumors -should be sensitive to ADAR1 loss.
228
Important clinical implications can be drawn from these observations. Our data suggest 229 that ADAR1 is a legitimate candidate for targeted therapies in TNBC. We found that TNBC cell MgCl 2 , 2.5 mM DTT, 0.2 mg/mL heparin, 10 µg/mL cycloheximide). The gradients were 442 subjected to centrifugation at 30,000 RPM for 3 hours at 4 °C. The absorbance at 254 nm was 443 measured along the gradient using a fractionation system (Teledyne ISCO).
444
Analysis of rRNA integrity 445
For analysis of rRNA integrity, total RNA isolated from cells of interest as described 446 above was denatured in 1x RNA Loading Dye (NEB) containing 100 ng/µL ethidium bromide 447 by incubation at 65 °C for 10 minutes. The denatured RNA was resolved on a 1.5% denaturing 448 formaldehyde agarose gel as described previously (Rio, 2015) . 
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Analysis of CCLE RNAseq Data and ADAR1 Dependency
